Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Grieve

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Plos One|September 12, 2013
Functional outcome, revision rates and mortality after primary total hip replacement--a national comparison of nine prosthesis brands in EnglandMark Pennington, Richard Grieve, Nick Black, et al.
Statistical Methods in Medical Research|February 15, 2014
Evaluating treatment effectiveness under model misspecification: A comparison of targeted maximum likelihood estimation with bias-corrected matchingNoémi Kreif, Susan Gruber, Rosalba Radice, et al.
Health Services Research|March 22, 2008
Evaluating health care programs by combining cost with quality of life measures: a case study comparing capitation and fee for serviceRichard Grieve, Jasjeet S Sekhon, Teh-Wei Hu, et al.
Health Services & Outcomes Research Methodology|June 25, 2016
Estimating causal effects: considering three alternatives to difference-in-differences estimationStephen O'Neill, Noémi Kreif, Richard Grieve, et al.
International Journal of Technology Assessment in Health Care|April 19, 2003
A cost-effectiveness analysis of rhDNase in children with cystic fibrosisRichard Grieve, Simon Thompson, Charles Normand, et al.
Journal of the Royal Society of Medicine|August 24, 2023
The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?Aris Angelis, Ajay Aggarwal, Alec Miners, et al.
Intensive Care Medicine|May 9, 2018
Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strainSteve Harris, Mervyn Singer, Colin Sanderson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 10, 2023
Emulating Target Trials With Real-World Data to Inform Health Technology Assessment: Findings and Lessons From an Application to Emergency SurgerySilvia Moler-Zapata, Andrew Hutchings, Stephen O'Neill, et al.
Intensive Care Medicine|June 20, 2018
Correction to: Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strainSteve Harris, Mervyn Singer, Colin Sanderson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United KingdomSue Langham, Antony Wright, James Kenworthy, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Plos One|September 12, 2013
Functional outcome, revision rates and mortality after primary total hip replacement--a national comparison of nine prosthesis brands in EnglandMark Pennington, Richard Grieve, Nick Black, et al.
Statistical Methods in Medical Research|February 15, 2014
Evaluating treatment effectiveness under model misspecification: A comparison of targeted maximum likelihood estimation with bias-corrected matchingNoémi Kreif, Susan Gruber, Rosalba Radice, et al.
Health Services Research|March 22, 2008
Evaluating health care programs by combining cost with quality of life measures: a case study comparing capitation and fee for serviceRichard Grieve, Jasjeet S Sekhon, Teh-Wei Hu, et al.
Health Services & Outcomes Research Methodology|June 25, 2016
Estimating causal effects: considering three alternatives to difference-in-differences estimationStephen O'Neill, Noémi Kreif, Richard Grieve, et al.
International Journal of Technology Assessment in Health Care|April 19, 2003
A cost-effectiveness analysis of rhDNase in children with cystic fibrosisRichard Grieve, Simon Thompson, Charles Normand, et al.
Journal of the Royal Society of Medicine|August 24, 2023
The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?Aris Angelis, Ajay Aggarwal, Alec Miners, et al.
Intensive Care Medicine|May 9, 2018
Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strainSteve Harris, Mervyn Singer, Colin Sanderson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 10, 2023
Emulating Target Trials With Real-World Data to Inform Health Technology Assessment: Findings and Lessons From an Application to Emergency SurgerySilvia Moler-Zapata, Andrew Hutchings, Stephen O'Neill, et al.
Intensive Care Medicine|June 20, 2018
Correction to: Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strainSteve Harris, Mervyn Singer, Colin Sanderson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United KingdomSue Langham, Antony Wright, James Kenworthy, et al.
Pageof 13